# US 8,278,266 B2 · Inhibition of migration and induction of cell death by the type II collagen amino propeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,266 B2
- Document ID: US8278266B2
- Status: Granted
- Kind: B2
- Application number: 12/836,832
- Filed: 2010-07-15
- Published: 2010-11-04
- Granted: 2012-10-02
- Earliest claimed: 2007-04-05
- Assignees: Washington University
- Inventors: Linda Sandell; Zhepeng Wang
- Web page: https://patentgrep.com/patent/US8278266B2

## CPC

- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides combinations and methods for inducing cell death, inhibiting angiogenesis, and inhibiting cell migration. In particular, the present invention provides methods for inducing cell death in a cell expressing an αvβ3 and/or an αvβ5 integrin.

## Claims

### Claim 1

A combination, the combination comprising an isolated human Type IIB collagen amino propeptide, wherein the propeptide consists of the amino acid sequence encoded by exons 3-8 of the human Type IIB collagen amino propeptide nucleic acid sequence, and an agent selected from the group consisting of an imaging agent and a therapeutic agent.

### Claim 2 (depends on 1)

The combination of claim 1, wherein the therapeutic agent is an anti-cancer agent.

### Claim 3 (depends on 1)

The combination of claim 1, wherein the human Type IIB collagen amino propeptide comprises a pharmaceutical composition.

### Claim 4 (depends on 1)

The combination of claim 1, wherein the imaging agent is an optical imaging agent.

### Claim 5 (depends on 1)

The combination of claim 1, wherein the imaging agent is a radiological imaging agent.

### Claim 6 (depends on 1)

The combination of claim 1, wherein the therapeutic agent is a chemotherapeutic agent.

### Claim 7 (depends on 1)

The combination of claim 1, wherein the therapeutic agent is a radiotherapeutic agent.

### Claim 8 (depends on 1)

The combination of claim 1, wherein the therapeutic agent is a hormonal therapeutic agent.

### Claim 9 (depends on 1)

The combination of claim 1, wherein the therapeutic agent is an immunotherapeutic agent.
